Home Medicine Primary hyperparathyroidism may masquerade as rickets-osteomalacia in vitamin D replete children
Article
Licensed
Unlicensed Requires Authentication

Primary hyperparathyroidism may masquerade as rickets-osteomalacia in vitamin D replete children

  • Mohd Ashraf Ganie EMAIL logo , Nishant Raizada , Himika Chawla , Arun Kumar Singh , Sandeep Aggarwala and Chandra Sekhar Bal
Published/Copyright: October 6, 2016

Abstract

Primary hyperparathyroidism, typically a disease of the middle aged and the old, is less commonly seen in children. In children the disease has a bimodal age distribution with calcium sensing receptor mutation presenting in infancy as hypercalcemic crises and parathyroid adenoma or hyperplasia presenting later in childhood with bone disease. The childhood parathyroid adenomas are often familial with multiglandular disease and manifest with severe bone disease unlike adults. We report a series of four male patients with juvenile primary hyperparathyroidism, three of whom presented with bone disease masquerading as rickets-osteomalacia. One patient had asymptomatic hypercalcemia with short stature. Parathyroid adenoma was detected in all the four cases and all of them underwent resection of parathyroid adenomas confirmed on histopathology. Post-surgery all the cases had initial hypocalcaemia followed by normocalcemia. One case developed pancreatitis after surgery even after achieving normocalcemia. We conclude that parathyroid adenomas, although uncommon in children, are an important cause of skeletal disease that may initially be confused with hypovitaminosis D.


Corresponding author: Dr. Mohd Ashraf Ganie, Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi-110029, India, Phone: +91-11-26593968, +91-9868856888

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res Off J Am Soc Bone Miner Res 2006;21:171–7.10.1359/JBMR.050910Search in Google Scholar PubMed

2. Walczyk A, Szalecki M, Kowalska A. Primary hyperparathyroidism: a rare endocrinopathy in children. Two case reports. Endokrynol Pol 2011;62:346–50.Search in Google Scholar

3. Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, et al. Primary hyperparathyroidism in pediatric patients. Pediatrics 2005;115:974–80.10.1542/peds.2004-0804Search in Google Scholar PubMed

4. Alagaratnam S, Kurzawinski TR. Aetiology, diagnosis and surgical treatment of primary hyperparathyroidism in children: new trends. Horm Res Paediatr 2015;83:365–75.10.1159/000381622Search in Google Scholar PubMed

5. Roizen J, Levine MA. A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults. J Clin Endocrinol Metab 2014;99:4555–64.10.1210/jc.2014-2268Search in Google Scholar PubMed PubMed Central

6. Marwaha RK, Tandon N, Reddy DR, Aggarwal R, Singh R, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005;82:477–82.10.1093/ajcn/82.2.477Search in Google Scholar

7. Ramkumar S, Kandasamy D, Vijay MK, Tripathi M, Jyotsna VP. Genu valgum and primary hyperparathyroidism in children. Int J Case Rep Images 2014;5:401–7.10.5348/ijcri-201455-CS-10041Search in Google Scholar

8. Dutta D, Kumar M, Das RN, Datta S, Biswas D, et al. Primary hyperparathyroidism masquerading as rickets: diagnostic challenge and treatment outcomes. J Clin Res Pediatr Endocrinol 2013;5:266–9.10.4274/Jcrpe.1060Search in Google Scholar PubMed PubMed Central

9. Kataria R, Agarwala S, Mitra DK, Kaur G, Chattopadhyay TK, et al. Primary hyperparathyroidism in children. Pediatr Surg Int 2013;11:374–7.10.1007/BF00497816Search in Google Scholar PubMed

10. Anitha A, Babu K, Siddini V, Ballal HS. Primary hyperparathyroidism in a child. Indian J Nephrol 2015;25:171–3.10.4103/0971-4065.147375Search in Google Scholar PubMed PubMed Central

11. Menon P, Dayal D, Rao SG, Bhattacharya A, Narasimha Rao KL. Childhood parathyroid adenoma: a rare but important cause of nephrolithiasis. J Pediatr Endocrinol Metab 2016;29: 853–6.10.1515/jpem-2015-0369Search in Google Scholar PubMed

12. Akyay A, Cihangiroglu G, Özkan Y, Deveci U, Bahceci S, et al. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood. J Pediatr Endocrinol Metab 2013;26:1185–8.10.1515/jpem-2012-0421Search in Google Scholar PubMed

Received: 2016-1-12
Accepted: 2016-7-18
Published Online: 2016-10-6
Published in Print: 2016-10-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. An update on thyroid-associated ophthalmopathy in children and adolescents
  4. Mini Review
  5. Systematic review and meta-analysis of the association between mumps during childhood and risk of type 1 diabetes mellitus
  6. Original Articles
  7. Glycemic variability predicts inflammation in adolescents with type 1 diabetes
  8. Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes
  9. One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome
  10. The outcome of seven patients with hereditary tyrosinemia type 1
  11. Increased oxidative stress parameters in children with moderate iodine deficiency
  12. Relationship between 25(OH)D levels and circulating lipids in African American adolescents
  13. Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10–18 years
  14. Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with atorvastatin in adolescents with type 1 diabetes
  15. Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center
  16. Pituitary volume in children with growth hormone deficiency, idiopathic short stature and controls
  17. Case Reports
  18. A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism
  19. Primary hyperparathyroidism may masquerade as rickets-osteomalacia in vitamin D replete children
  20. Co-existence of phenylketonuria either with maple syrup urine disease or Sandhoff disease in two patients from Iran: emphasizing the role of consanguinity
  21. Severe malnutrition causing superior mesenteric artery syndrome in an adolescent with Triple A syndrome
  22. Solving a case of allelic dropout in the GNPTAB gene: implications in the molecular diagnosis of mucolipidosis type III alpha/beta
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2016-0018/html
Scroll to top button